Funding Opportunity Announcement - NIBIB Technology Development Networks
ID: 360629Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $1M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360629
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a funding opportunity for the NIBIB Technology Development Networks, aimed at establishing Coordinating Centers that will facilitate collaboration among scientific and engineering communities to address translational challenges in health technology development. These centers will enhance integration across various technology development projects, disseminate program advancements, and manage an Opportunity Funds program to support promising small-scale initiatives. With an estimated total program funding of $1 million and a projected award ceiling of $1 million, this cooperative agreement is expected to yield one award, with applications not currently being solicited. Interested parties are encouraged to prepare for future submissions, with key dates including an estimated synopsis post date of May 1, 2026, and an estimated award date of April 1, 2027. For further inquiries, potential applicants can contact Luisa Russell via email at luisa.russell@nih.gov.

    Point(s) of Contact
    Luisa Russell
    Please contact via e-mail.
    luisa.russell@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.
    Notice of Intent to Publish a Funding Opportunity Announcement: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for research focused on developing biomedical technologies that address health disparities. This initiative seeks to support projects that create effective, affordable, and socially acceptable technologies to improve healthcare access and outcomes for underserved populations. The estimated total program funding for this opportunity is $1,200,000, with an expected two awards to be made, and the application process is anticipated to open in late 2025. Interested applicants can reach out to Nichole Daringer at nichole.daringer@nih.gov or call 301-451-4774 for further information.
    Forecast for Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the Blueprint MedTech Translator program, aimed at supporting small businesses in the development of innovative medical devices for the nervous and neuromuscular systems. This cooperative agreement will provide non-dilutive funding and additional resources to facilitate the translation of groundbreaking technologies from early-stage development to clinical studies, ultimately accelerating patient access to effective medical devices. Interested applicants should note that while applications are not currently being solicited, they are encouraged to begin forming collaborations and developing projects in anticipation of the NOFO, with an estimated synopsis posting date of July 21, 2025, and a closing date of October 20, 2025. For further inquiries, potential applicants can contact Nicholas Langhals, PhD, at Blueprint-MedTech@nih.gov or by phone at 301-435-0090.
    Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory research grants (R21) aimed at developing innovative technologies in biomedical research. This initiative seeks applications that propose high-risk, high-reward projects focused on technology development without existing proof of concept, specifically excluding clinical trials. The funding amount is capped at $275,000 in direct costs over two years, with a maximum of $200,000 available in any single year. Interested applicants, including higher education institutions and nonprofit organizations, must adhere to submission guidelines and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The application deadline is January 7, 2028.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers, aimed at expanding an international cardiac surgery research platform. This initiative will focus on integrating various areas of research, including interventional cardiology, peri-operative care, dissemination and implementation science, circadian medicine, and mechanistic science, to enhance the health outcomes of adults with cardiovascular disease and related neurologic complications. The platform will also serve as a training ground for future clinical trialists and implementation researchers, fostering collaboration among academia, small businesses, and other stakeholders. While applications are not currently being solicited, interested parties are encouraged to prepare for future submissions, with the estimated synopsis post date set for February 2, 2026, and the estimated project start date anticipated for January 1, 2027. For further inquiries, potential applicants can contact Dr. Kathleen Fenton at kathleen.fenton@nih.gov or by phone at 301-221-7865.
    Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Biomedical Technology Optimization and Dissemination Centers (BTOD) aimed at supporting late-stage technology optimization and dissemination within the biomedical research community. This initiative encourages applications that focus on optimizing lab-proven technologies and enhancing their usability, with an emphasis on collaborative projects and community engagement strategies to ensure inclusivity and sustainability. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and local governments, with a maximum annual budget of $850,000 available for funding, excluding specialized equipment costs. Interested parties should note that the application deadline is January 27, 2026, and can find further details and submission guidelines at the NIH grants website or by contacting NIH Grants Information at grantsinfo@nih.gov.
    Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities" aimed at enhancing research capacity and innovation in bioengineering and biomedical imaging at HBCUs. This initiative aligns with the HBCU PARTNERS Act and seeks to foster collaborations that promote scientific growth and competitiveness in federal research funding. The estimated total program funding is $1,920,000, with four awards anticipated, and interested applicants are encouraged to prepare their proposals ahead of the expected synopsis posting on March 10, 2026, with applications due by June 1, 2026. For further inquiries, potential applicants can contact David Gutekunst, PhD, via email at dave.gutekunst@nih.gov.
    Notice of Intent to Publish a Notice of Funding Opportunity for National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a Notice of Funding Opportunity (NOFO) for the National Centers for Biomedical Imaging and Bioengineering (NCBIB), with a focus on advancing research in biomedical imaging and bioengineering. This grant opportunity, identified as P41 Clinical Trials Optional, aims to foster meaningful collaborations and innovative projects within the research community. The anticipated funding amount for this initiative is up to $750,000, with the NOFO expected to be published in late summer 2023 and applications due in fall 2023. Interested applicants should prepare for the estimated project start date of July 30, 2024, and can expect the award announcement by June 30, 2024.